There is a movement in medicine to require that applications for licenses to sell a new drug be “evidence-based.” By contrast, trained economists view their discipline as having already achieved this scientific standard. After all, they express their ideas with mathematics and arrive at quantitative estimates of implied relationships from empirical data.
There is a movement in medicine to require that applications for licenses to sell a new drug be “evidence-based.” By contrast, trained economists view their discipline as having already achieved this scientific standard. After all, they express their ideas with mathematics and arrive at quantitative estimates of implied relationships from empirical data.